Skip to main content
CNSX:MMJ

Matica Enterprises Competitors

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume287,225 shs
Average Volume79,508 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Matica Enterprises (CNSX:MMJ) Vs. CHV, PREV, COM, MYM, CURE, and HALO

Should you be buying MMJ stock or one of its competitors? Companies in the industry of "biotechnology" are considered alternatives and competitors to Matica Enterprises, including (CHV) (CHV), (PREV) (PREV), 138267 (COM.TO) (COM), 17031 (MYM), Direxion Daily Healthcare Bull 3X Shares (CURE), and Halozyme Therapeutics (HALO).

Matica Enterprises (CNSX:MMJ) and (CHV) (CNSX:CHV) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, earnings, profitability, dividends, risk, institutional ownership and analyst recommendations.

Analyst Recommendations

This is a breakdown of recent ratings for Matica Enterprises and (CHV), as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Matica Enterprises0000N/A
(CHV)0000N/A

Profitability

This table compares Matica Enterprises and (CHV)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Matica EnterprisesN/AN/AN/A
(CHV)N/AN/AN/A

Valuation & Earnings

This table compares Matica Enterprises and (CHV)'s gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Matica EnterprisesN/AN/AN/AN/AN/A
(CHV)N/AN/AN/AN/AN/A

Matica Enterprises (CNSX:MMJ) and (PREV) (CNSX:PREV) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, earnings, profitability, dividends, risk, institutional ownership and analyst recommendations.

Analyst Recommendations

This is a breakdown of recent ratings for Matica Enterprises and (PREV), as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Matica Enterprises0000N/A
(PREV)0000N/A

Profitability

This table compares Matica Enterprises and (PREV)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Matica EnterprisesN/AN/AN/A
(PREV)N/AN/AN/A

Valuation & Earnings

This table compares Matica Enterprises and (PREV)'s gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Matica EnterprisesN/AN/AN/AN/AN/A
(PREV)N/AN/AN/AN/AN/A

Matica Enterprises (CNSX:MMJ) and 138267 (COM.TO) (TSE:COM) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, earnings, profitability, dividends, risk, institutional ownership and analyst recommendations.

Profitability

This table compares Matica Enterprises and 138267 (COM.TO)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Matica EnterprisesN/AN/AN/A
138267 (COM.TO)N/AN/AN/A

Valuation & Earnings

This table compares Matica Enterprises and 138267 (COM.TO)'s gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Matica EnterprisesN/AN/AN/AN/AN/A
138267 (COM.TO)N/AN/AN/AN/AN/A

Analyst Recommendations

This is a breakdown of recent ratings for Matica Enterprises and 138267 (COM.TO), as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Matica Enterprises0000N/A
138267 (COM.TO)0000N/A

17031 (CNSX:MYM) and Matica Enterprises (CNSX:MMJ) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, earnings, risk, valuation, institutional ownership, dividends and analyst recommendations.

Profitability

This table compares 17031 and Matica Enterprises' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
17031N/AN/AN/A
Matica EnterprisesN/AN/AN/A

Earnings and Valuation

This table compares 17031 and Matica Enterprises' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
17031N/AN/AN/AN/AN/A
Matica EnterprisesN/AN/AN/AN/AN/A

Analyst Ratings

This is a breakdown of recent recommendations and price targets for 17031 and Matica Enterprises, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
170310000N/A
Matica Enterprises0000N/A

Direxion Daily Healthcare Bull 3X Shares (CNSX:CURE) and Matica Enterprises (CNSX:MMJ) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, earnings, risk, valuation, institutional ownership, dividends and analyst recommendations.

Profitability

This table compares Direxion Daily Healthcare Bull 3X Shares and Matica Enterprises' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Direxion Daily Healthcare Bull 3X SharesN/AN/AN/A
Matica EnterprisesN/AN/AN/A

Earnings and Valuation

This table compares Direxion Daily Healthcare Bull 3X Shares and Matica Enterprises' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Direxion Daily Healthcare Bull 3X SharesN/AN/AN/AN/AN/A
Matica EnterprisesN/AN/AN/AN/AN/A

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Direxion Daily Healthcare Bull 3X Shares and Matica Enterprises, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Direxion Daily Healthcare Bull 3X Shares0000N/A
Matica Enterprises0000N/A

Halozyme Therapeutics (NEO:HALO) and Matica Enterprises (CNSX:MMJ) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, earnings, risk, valuation, institutional ownership, dividends and analyst recommendations.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Halozyme Therapeutics and Matica Enterprises, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Halozyme Therapeutics00014.00
Matica Enterprises0000N/A

Halozyme Therapeutics presently has a consensus target price of C$0.24, indicating a potential upside of ∞.

Earnings and Valuation

This table compares Halozyme Therapeutics and Matica Enterprises' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Halozyme TherapeuticsC$331.26 million0.00C$160.33 millionC$1.13N/A
Matica EnterprisesN/AN/AN/AN/AN/A

Halozyme Therapeutics has higher revenue and earnings than Matica Enterprises.

Profitability

This table compares Halozyme Therapeutics and Matica Enterprises' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Halozyme TherapeuticsN/AN/AN/A
Matica EnterprisesN/AN/AN/A

Summary

Halozyme Therapeutics beats Matica Enterprises on 2 of the 2 factors compared between the two stocks.


Matica Enterprises Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
CHV
(CHV)
0.5N/AN/A$0.00N/A0.00High Trading Volume
PREV
(PREV)
0.7N/AN/A$0.00N/A0.00High Trading Volume
COM
138267 (COM.TO)
0.5N/AN/AC$0.00N/A0.00
MYM
17031
0.4N/AN/AC$0.00N/A0.00
CURE
Direxion Daily Healthcare Bull 3X Shares
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
HALO
Halozyme Therapeutics
1.7N/AN/AC$0.00C$331.26 million47.29Earnings Announcement
LTY
Liberty Biopharma
0.6$2.00flatC$0.00N/A-12.66Gap Up
SCYB
Scythian Biosciences
0.5$3.49flatC$0.00N/A0.00High Trading Volume
ABCN
VIVO Cannabis
0.6$1.32flatC$0.00N/A0.00Gap Up
VP
Vodis Pharmaceuticals
0.6N/AN/A$0.00N/A0.00High Trading Volume
Gap Down
This page was last updated on 5/16/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.